ERNA vs. FATN

Last updated Aug 1, 2026

ERNA (Eterna Therapeutics Inc) and FATN (FatPipe, Inc) are both stocks. ERNA operates in Biotechnology (Healthcare), while FATN operates in Software - Infrastructure (Technology). Over the past year, ERNA returned -91.59% vs 3.58% for FATN. Their 0.04 correlation means their historical movements had little consistent relationship.

Performance

ERNA vs. FATN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Eterna Therapeutics Inc (ERNA) and FatPipe, Inc (FATN). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ERNA achieves a -89.07% return, which is significantly lower than FATN's 200.99% return.

ERNA

• 1D: -5.48%
• 1M: -47.69%
• 6M: -89.25%
• YTD: -89.07%
• 1Y: -91.59%
• 3Y*: -85.19%
• 5Y*: -86.94%
• 10Y*: -64.30%
• ALL TIME*: -33.20%

FATN

• 1D: 18.75%
• 1M: 1.67%
• 6M: 241.57%
• YTD: 200.99%
• 1Y: 3.58%
• 3Y*: —
• 5Y*: —
• 10Y*: —
• ALL TIME*: -4.97%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
ERNA Eterna Therapeutics Inc	$350.09K	$8.77M	$15.38M
FATN FatPipe, Inc	$555.65K	$467.45K	$1.86M

ERNA vs. FATN - Yearly Performance Comparison

	2026 (YTD)	2025
ERNA Eterna Therapeutics Inc	-89.07%	-57.08%
FATN FatPipe, Inc	200.99%	-68.92%

Correlation

The correlation between ERNA and FATN is 0.03, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.03
Correlation (All Time) Calculated using the full available price history since Apr 8, 2025	0.04

Fundamentals

Market Cap ERNA : $1.03M FATN : $85.27M
EPS ERNA : -$23.80 FATN : $0.39
PB Ratio ERNA : 0.38 FATN : 3.23
Total Revenue (TTM) ERNA : $0.00 FATN : $20.30M
Gross Profit (TTM) ERNA : -$69.00K FATN : $17.68M
EBITDA (TTM) ERNA : -$11.25M FATN : $4.11M

Return for Risk

ERNA vs. FATN — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

ERNA

ERNA Risk / Return Rank: 8
ERNA Sharpe Ratio Rank: 17
ERNA Sortino Ratio Rank: 6
ERNA Omega Ratio Rank: 8
ERNA Calmar Ratio Rank: 2
ERNA Martin Ratio Rank: 6

FATN

FATN Risk / Return Rank: 50
FATN Sharpe Ratio Rank: 42
FATN Sortino Ratio Rank: 63
FATN Omega Ratio Rank: 60
FATN Calmar Ratio Rank: 41
FATN Martin Ratio Rank: 42

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

ERNA vs. FATN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Eterna Therapeutics Inc (ERNA) and FatPipe, Inc (FATN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ERNA	FATN	Difference
Sharpe ratio: Return per unit of total volatility	-0.60	-0.05	-0.55
Sortino ratio: Return per unit of downside risk	-1.53	1.20	-2.73
Omega ratio: Gain probability vs. loss probability	0.82	1.14	-0.32
Calmar ratio: Return relative to maximum drawdown	-0.99	-0.09	-0.91
Martin ratio: Return relative to average drawdown	-1.47	-0.12	-1.35

ERNA vs. FATN - Sharpe Ratio Comparison

The current ERNA Sharpe Ratio is -0.60, which is lower than the FATN Sharpe Ratio of -0.05. The chart below compares the historical Sharpe Ratios of ERNA and FATN, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

ERNA vs. FATN - Drawdown Comparison

The maximum ERNA drawdown since its inception was -100.00%, which is greater than FATN's maximum drawdown of -88.85%. Use the drawdown chart below to compare losses from any high point for ERNA and FATN.

Drawdown Indicators

	ERNA	FATN	Difference
Max Drawdown Largest peak-to-trough decline	-100.00%	-88.85%	-11.15%
Max Drawdown (1Y) Largest decline over 1 year	-93.02%	-83.69%	-9.33%
Max Drawdown (3Y) Largest decline over 3 years	-99.70%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-100.00%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-100.00%	—	—
Current Drawdown Current decline from peak	-100.00%	-53.23%	-46.77%
Average Drawdown Average peak-to-trough decline	-86.20%	-60.81%	-25.39%
Ulcer Index Depth and duration of drawdowns from previous peaks	62.71%	58.83%	+3.88%

Volatility

ERNA vs. FATN - Volatility Comparison

Eterna Therapeutics Inc (ERNA) has a higher volatility of 35.09% compared to FatPipe, Inc (FATN) at 31.02%. This indicates that ERNA's price experiences larger fluctuations and is considered to be riskier than FATN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ERNA	FATN	Difference
Volatility (1M) Calculated over the trailing 1-month period	35.09%	31.02%	+4.07%
Volatility (6M) Calculated over the trailing 6-month period	132.84%	115.72%	+17.12%
Volatility (1Y) Calculated over the trailing 1-year period	154.51%	150.70%	+3.81%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	114.04%	178.32%	-64.28%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	149.29%	178.32%	-29.03%

Dividends

ERNA vs. FATN - Dividend Comparison

Neither ERNA nor FATN has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both ERNA and FATN in my portfolio?

ERNA and FATN have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ERNA or FATN?

ERNA has higher volatility (35.09%) compared to FATN (31.02%). In terms of maximum drawdown, ERNA dropped -100.00% vs FATN's -88.85%.

Which has better risk-adjusted returns?

FATN currently has the higher Sharpe Ratio (-0.05 vs -0.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.